- Home
- RBB vs PRME Comparison
RBB vs PRME Comparison
Compare RBB & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RBB
- PRME
- Stock Information
- Founded
- RBB 2008
- PRME 2019
- Country
- RBB United States
- PRME United States
- Employees
- RBB N/A
- PRME N/A
- Industry
- RBB Major Banks
- PRME Medicinal Chemicals and Botanical Products
- Sector
- RBB Finance
- PRME Health Care
- Exchange
- RBB Nasdaq
- PRME Nasdaq
- Market Cap
- RBB 374.0M
- PRME 379.1M
- IPO Year
- RBB 2017
- PRME 2022
- Fundamental
- Price
- RBB $20.09
- PRME $2.89
- Analyst Decision
- RBB Hold
- PRME Strong Buy
- Analyst Count
- RBB 4
- PRME 9
- Target Price
- RBB $20.88
- PRME $13.13
- AVG Volume (30 Days)
- RBB 40.2K
- PRME 1.1M
- Earning Date
- RBB 02-03-2025
- PRME 02-28-2025
- Dividend Yield
- RBB 3.19%
- PRME N/A
- EPS Growth
- RBB N/A
- PRME N/A
- EPS
- RBB 1.87
- PRME N/A
- Revenue
- RBB $115,630,000.00
- PRME $800,000.00
- Revenue This Year
- RBB N/A
- PRME N/A
- Revenue Next Year
- RBB $5.94
- PRME $426.55
- P/E Ratio
- RBB $10.77
- PRME N/A
- Revenue Growth
- RBB N/A
- PRME N/A
- 52 Week Low
- RBB $16.49
- PRME $2.56
- 52 Week High
- RBB $25.30
- PRME $9.77
- Technical
- Relative Strength Index (RSI)
- RBB 40.06
- PRME 45.80
- Support Level
- RBB $18.32
- PRME $2.63
- Resistance Level
- RBB $20.48
- PRME $2.92
- Average True Range (ATR)
- RBB 0.57
- PRME 0.22
- MACD
- RBB 0.08
- PRME 0.00
- Stochastic Oscillator
- RBB 66.04
- PRME 27.08
About RBB RBB Bancorp
RBB Bancorp operates as a bank holding company. It provides various banking products and services such as checking, savings, money market accounts, and certificates of deposits. Its Specific services include remote deposit, E-banking, mobile banking, commercial and investor real estate loans, business loans and lines of credit, Small Business Administration (SBA) 7A and 504 loans, mortgage loans, trade finance, and a full range of depository accounts. It generates its revenue from interest received on loans and leases and, to a lesser extent, from interest received on investment securities and derives income from noninterest sources, such as fees received in connection with various lending and deposit services, loan servicing, gain on sales of loans, and wealth management services.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.